SCHEMBL138030

SCHEMBL138030

[C]#CCCC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL138654 0.81
SCHEMBL2119525 0.79
SCHEMBL386801 0.77 LMNA (0.43)
SCHEMBL384257 0.77 LMNA (0.43)
SCHEMBL139056 0.77 LMNA (0.43)
SCHEMBL3024018 0.77 LMNA (0.43)
SCHEMBL385784 0.77 LMNA (0.43)
SCHEMBL7090813 0.75
SCHEMBL7091888 0.75
SCHEMBL2124717 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024096066-A1 CYCLIC PEPTIDE DERIVATIVE COMPOSITION FOR TREATING OR PREVENTING CENTRAL NERVOUS SYSTEM INJURY/DISEASE 第一工業製薬株式会社 2024-05-10 WO disclosed
WO-2024096067-A1 CYCLIC PEPTIDE DERIVATIVE COMPOSITION FOR TREATING OR PREVENTING NEUROPATHIC PAIN AND/OR INFLAMMATORY PAIN 第一工業製薬株式会社 2024-05-10 WO disclosed
CN-114907354-B Sulfonamide polycyclic compound and preparation method and application thereof 南京知和医药科技有限公司 2024-04-09 CN disclosed
CN-117832494-A Battery cell 珠海冠宇电池股份有限公司 2024-04-05 CN disclosed
WO-2024071370-A1 CYCLIC PEPTIDE DERIVATIVE COMPOSITION FOR TREATING OR PREVENTING EYE DISEASE 第一工業製薬株式会社 2024-04-04 WO disclosed
WO-2024071371-A1 HETEROCYCLIC COMPOUND ユビエンス株式会社 2024-04-04 WO disclosed
CN-117625047-A Pressure-sensitive adhesive composition and optical pressure-sensitive adhesive 株式会社LMS 2024-03-01 CN disclosed
WO-2024029630-A1 CYCLIC PEPTIDE DERIVATIVE, METHOD FOR PRODUCING SAME, AND COMPOSITION 第一工業製薬株式会社 2024-02-08 WO disclosed
EP-3223952-B1 ENERGY INPUT DURING AGGLOMERATION FOR MAGNETIC SEPARATION BASF SE (DE) 2024-01-17 EP disclosed
EP-4301520-A1 MAGNETIC SEPARATION OF PARTICLES SUPPORTED BY SPECIFIC SURFACTANTS BASF SE (DE) 2024-01-10 EP disclosed
EP-0657450-A1 INDAZOLESULFONYLUREA DERIVATIVE, USE THEREOF, AND INTERMEDIATE FOR PRODUCTION THEREOF KumaiI Chemical Industry Co., Ltd. (JP) 1995-06-14 EP disclosed
EP-0648752-A1 TRIAZOLE DERIVATIVE, INSECTICIDAL/ACARICIDAL AGENT, AND PROCESS FOR PRODUCING THE SAME KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 1995-04-19 EP disclosed
EP-0638312-A1 DERMATOLOGIC PREPARATION COMPOSITION CONTAINING ISOCARBACYCLIN AS ACTIVE INGREDIENT TEIJIN LIMITED (JP) 1995-02-15 EP disclosed
EP-0634171-A1 PHARMACEUTICAL COMPOSITION FOR TREATING CEREBRAL THROMBOSIS TEIJIN LIMITED (JP) 1995-01-18 EP disclosed
US-5350743-A Treatment of osteoporosis KAKEN PHARMACEUTICAL CO., LTD. (JP) 1994-09-27 US disclosed
US-5318959-A A new miticides diaryl alkyl 1,2,4-triazoles KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 1994-06-07 US disclosed
EP-0572142-A2 Novel 3,5-diphenyl substituted 1,2,4-triazoles and their use as insecticides and acaricides KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 1993-12-01 EP disclosed
EP-0498424-A1 Bisphosphonic acid derivatives and bone resorption inhibitors containing them Kaken Pharmaceutical Co., Ltd. (JP) 1992-08-12 EP disclosed
US-4396735-A N-HETEROCYCLIC COMPOUND AND A HETEROCYCLIC ACID HYDRAZIDE ADEKA ARGUS CHEMICAL CO., LTD. (JP) 1983-08-02 US disclosed
US-4362831-A A HINDERED AND HETEROCYCLIC AMINE WITH A THIOALKANOIC ACID AMIDE ADEKA ARGUS CHEMICAL CO., LTD. (JP) 1982-12-07 US disclosed